| D-05 Sarah Lobet Target-response relationship of bevacizumab may be more relevant than exposure-response - a target-mediated drug disposition (TMDD) model Friday 10:15-0:35 |
| D-05 Sarah Lobet Target-response relationship of bevacizumab may be more relevant than exposure-response - a target-mediated drug disposition (TMDD) model Friday 10:15-0:35 |